跳至主要内容
临床试验/NCT01324297
NCT01324297终止不适用

The Topical Niacin Skin Flush Test: A Means for Longitudinal Monitoring of Two Different Biological Subgroups of Patients With First Episode Psychosis

Nova Scotia Health Authority1 个研究点 分布在 1 个国家目标入组 107 人开始时间: 2011年12月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
107
试验地点
1
主要终点
change in visual rating of skin response (redness and oedema)

研究概览

简要总结

The purpose of this study is to gather normative data from healthy adults and to determine a sensitive and specific cut-off value for responders and non-responders to the Niacin Skin Flush Test in a sample of first episode psychosis patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
19 Years 至 30 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • caucasian
  • within twelve months of initial DSM IV TR diagnosis of schizophreniform psychosis, schizophrenia, schizoaffective disorder or psychotic disorder NOS
  • outpatient

排除标准

  • known allergy to study compound (methyl nicotinate, vitamin B3, niacin)
  • skin conditions (e.g., dermatitis, psoriasis, eczema)
  • diagnosis or treatment for medical conditions that may affect normal vascular tone (e.g., diabetes, vasculitis, chronic hypertension, etc.)
  • Use of anti-inflammatory, antibiotic, or antihistamine medications within one month prior to study entry
  • Use of supplements like Omega 3 fatty acids within 3 months prior to study entry
  • Use of vitamin or nutritional supplement containing a dose of niacin/nicotinic acid above 50 mg/day at study entry

结局指标

主要结局

change in visual rating of skin response (redness and oedema)

时间窗: ratings made at 3, 6, 9 and 12 minutes after application of methyl nicotinate

A 7-point visual rating scale, previously tested for reliability (Kerr 2008), to visually rate the skin response to aqueous methyl nicotinate (niacin) with respect to both redness and oedema as a function of increasing niacin concentrations.Ratings will be acquired every three minutes over a 12-minute period starting at the time of solution application.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Beverly Butler

Research Neuropsychologist

Nova Scotia Health Authority

研究点 (1)

Loading locations...

相似试验